COVID-19: PeaceHealth is open, with safe virtual and in-person visits.
Learn more about our safety measures and visitor restrictions.

Multiple Myeloma

  • A061202: A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib Vs. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy and Proteasome Inhibitor-Based Therapy
  • EAA173: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

  • For more information, contact Lauren Key, RN, BSN at 360-788-8238